Sequential ocular surgeries and multimodal immunosuppression for bilateral, medically refractory seronegative scleritis with severe peripheral corneal stromal thinning: a case report.
Saved in:
| Title: | Sequential ocular surgeries and multimodal immunosuppression for bilateral, medically refractory seronegative scleritis with severe peripheral corneal stromal thinning: a case report. |
|---|---|
| Authors: | Fidan DG; Faculty of Medicine, Koç University, Istanbul, Turkey., Butler NJ; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Veterans Affairs Boston Healthcare System, Department of Ophthalmology, Jamaica Plain, Boston, MA, USA., Kohanim S; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.; Veterans Affairs Boston Healthcare System, Department of Ophthalmology, Jamaica Plain, Boston, MA, USA., Liu C; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Yavuz Saricay L; Boston Medical Center, Boston, MA, USA.; Department of Ophthalmology, Boston Childrens Hospital, Harvard Medical School, Boston, MA, USA., Dohlman TH; Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA. Thomas_Dohlman@meei.harvard.edu.; Department of Ophthalmology, Boston Childrens Hospital, Harvard Medical School, Boston, MA, USA. Thomas_Dohlman@meei.harvard.edu.; Schepens Eye Research Institute of Massachusetts Eye and Ear, 20 Standiford Street, Boston, MA, 02114, USA. Thomas_Dohlman@meei.harvard.edu. |
| Source: | BMC ophthalmology [BMC Ophthalmol] 2026 Apr 16; Vol. 26 (1). Date of Electronic Publication: 2026 Apr 16. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
